Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 58 of 58, showing 6 Applications out of 576 total, starting on record 571, ending on 576

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

571.

ECCT/23/05/03   BrainCapture EEG Validation
          Usability and efficacy of an affordable, smartphone-connected EEG device to bridge the global gap in epilepsy diagnosis             
Principal Investigator(s)
1. Diraj Sokhi Sokhi
Site(s) in Kenya
Aga Khan University Hospital Nairobi
 
20-12-2023 View

572.

ECCT/24/02/07   CO-SAM
          An adaptive multi-arm trial to improve clinical outcomes among children recovering from complicated severe acute malnutrition (CO-SAM)             
Principal Investigator(s)
1. Benson Singa
Site(s) in Kenya
1. Homabay County Referral hospital (Homa Bay county)
2. Migori County Referral Hospital (Migori county)
3. Mbagathi County Referral Hospital (Nairobi City county)
4. Coast General Teaching and Referral Hospital (Mombasa county)
 
03-12-2024 View

573.

ECCT/24/04/06   REACH 2
    Realizing Effectiveness Across Continents with Hydroxyurea (REACH):  A Phase I/II Prospective Trial of Hydroxyurea for Children and Young Adults with Sickle Cell Anaemia       
Principal Investigator(s)
1. Thomas Williams
2. Russell Ware
Site(s) in Kenya
Kilifi County Referal Hospital
 
28-06-2024 View

574.

ECCT/19/03/04   NIFTY
      Non-Inferiority Fractional-Doses Trial For Yellow Fever Vaccine         
Principal Investigator(s)
1. George Warimwe
Site(s) in Kenya
KEMRI Kilifi
 
21-06-2019 View

575.

ECCT/14/11/01   ZEBOV Trial
      A Phase 1, Open-Label, Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the BPSC1001 (VSVΔG-ZEBOV) Ebola Virus Vaccine Candidate in Healthy Adult Volunteers in Kilifi, Kenya.                
Principal Investigator(s)
1. Philip Bejon
2. Patricia Njuguna
Site(s) in Kenya
KEMRI Wellcome Trust Research Programme
 
08-12-2014 View

576.

ECCT/18/08/03   PCVFRACTIONAL DOSE
    The effect of fractional doses of pneumococcal conjugate vaccines (PCV10 and PCV13) on immunogenicity and vaccine-serotype carriage in Kenyan infants       
Principal Investigator(s)
1. Anthony John Scott
Site(s) in Kenya
KEMRI-Wellcome Trust Research Programme (KWTRP) Centre for Geographic Medical Research - Coast (CGMRC), Kilifi, Kenya.
 
25-02-2019 View